Corporate calendar for Organon & Co. (OGN): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collection includes three immune-related medications (Brenzys, Renflexis, Hadlima) and two cancer therapies (Ontruzant, Aybintio).
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | ||
| 2026-09-15 | $-0.02 | |
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 |
Dividend History
| Date | Amount | Yield |
|---|---|---|
| 2026-08-14 | $0.0200 | 0.59% |
| 2026-05-11 | $0.0200 | 0.59% |
| 2026-02-23 | $0.0200 | 0.59% |
| 2025-11-20 | $0.0200 | 0.59% |
| 2025-08-15 | $0.0200 | 0.59% |
| 2025-05-12 | $0.0200 | 0.59% |
| 2025-02-24 | $0.2800 | 8.19% |
| 2024-11-12 | $0.2800 | 8.19% |
| 2024-08-16 | $0.2800 | 8.19% |
| 2024-05-10 | $0.2800 | 8.19% |
Price
| Price | $13.67 |
| Market Cap | $3.6B |
| Exchange | NYSE |
| Country | US |
Related companies: ALVO · AUPH · AVDL · GRDN · HRMY · MD · NUVB
Explore sector: Healthcare · Drug Manufacturers - General
More sections of OGN: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks